Stanford University School of Medicine is the medical school of Stanford University and is located in Stanford, California. It traces its roots to the Medical Department of the University of the Pacific, founded in San Francisco in 1858.

During the past decade, Stanford University School of Medicine conducted 262 clinical trials. In the 10-year time frame, 262 clinical trials started and 331 clinical trials were completed, i.e. on average, 126.3% percent of trials that started reached the finish line to date. In the past 5 years, 78 clinical trials started and 96 clinical trials were completed. i.e. 123.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stanford University School of Medicine" #1 sponsor was "Stanford University" with 574 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 27 trials sponsored, "DBV Technologies" with 8 trials sponsored, "Eben Rosenthal" with 8 trials sponsored and "Pfizer" with 8 trials sponsored. Other sponsors include 316 different institutions and companies that sponsored additional 214 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stanford University School of Medicine" #1 collaborator was "National Cancer Institute (NCI)" with 42 trials as a collaborator, "National Institutes of Health (NIH)" with 35 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 24 trials as a collaborator, "Genentech, Inc." with 14 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 12 trials as a collaborator. Other collaborators include 405 different institutions and companies that were collaborators in the rest 249 trials.

According to Clinical.Site data, the most researched conditions in "Stanford University School of Medicine" are "Breast Cancer" (44 trials), "HIV Infections" (27 trials), "Obesity" (24 trials), "Leukemia" (23 trials) and "Lung Cancer" (20 trials). Many other conditions were trialed in "Stanford University School of Medicine" in a lesser frequency.

Most popular intervention types in "Stanford University School of Medicine" are "Drug" (473 trials), "Procedure" (163 trials), "Device" (115 trials), "Behavioral" (104 trials) and "Other" (74 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (67 trials), "Zidovudine" (14 trials), "Cyclophosphamide" (11 trials), "Laboratory Biomarker Analysis" (11 trials) and "Cyclosporine" (9 trials). Other intervention names were less common.

The vast majority of trials in "Stanford University School of Medicine" are 805 trials for "All" genders, 106 trials for "Female" genders and 35 trials for "Male" genders.

Currently, there are 128 active trials in "Stanford University School of Medicine". 2 are not yet recruiting, 65 are recruiting, 52 are Active, not recruiting, and 9 are Enrolling by invitation. In total, there were 607 completed trials in Stanford University School of Medicine, 5 suspended trials, and 146 terminated clinical trials to date.

Out of the total trials that were conducted in Stanford University School of Medicine, 148 "Phase 1" clinical trials were conducted, 262 "Phase 2" clinical trials and 112 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 38 trials, and there were also 262 trials that are defined as “Not Applicable".